Niva Bupa Health Insurance IPO Overview
The Niva Bupa Health Insurance IPO is a highly anticipated book-built issue, aiming to raise Rs 2,200 crore. This comprises a fresh issue of 10.81 crore shares worth Rs 800 crore and an offer for sale of 18.92 crore shares, total Rs 1,400 crore.
Investors can subscribe to the Niva Bupa Health Insurance IPO between November 7, 2024, and November 11, 2024. The allotment will likely be finalized on November 12, with a tentative listing date on the BSE and NSE set for November 14, 2024.
Priced in a band of ₹70 to ₹74 per share, the minimum lot size for retail investors is 200 shares, requiring an initial investment of ₹14,800. For sNII investors, the minimum is 14 lots (2,800 shares) at ₹207,200, while bNII investors need at least 68 lots (13,600 shares) amounting to ₹1,006,400.
ICICI Securities Limited, Morgan Stanley India Company Pvt Ltd, Kotak Mahindra Capital Company Limited, Axis Capital Limited, HDFC Bank Limited and Motilal Oswal Investment Advisors Limited are the book running lead managers of the Niva Bupa Health Insurance IPO, while Kfin Technologies Limited is the registrar for the issue.
Niva Bupa Health Insurance IPO Important dates
Niva Bupa Health Insurance IPO opens on November 7, 2024, and closes on November 11, 2024.
IPO Open Date | Thursday, November 7, 2024 |
IPO Close Date | Monday, November 11, 2024 |
Basis of Allotment | Tuesday, November 12, 2024 |
Initiation of Refunds | Wednesday, November 13, 2024 |
Credit of Shares to Demat | Wednesday, November 13, 2024 |
Listing Date | Thursday, November 14, 2024 |
Cut-off time for UPI mandate confirmation | 5 PM on November 11, 2024 |
Niva Bupa Health Insurance IPO Financial Performance
Niva Bupa Health Insurance Company Limited’s revenue increased by 44.05% and profit after tax (PAT) rose by 552.73% between the financial year ending with March 31, 2024 and March 31, 2023.
Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | 6,542.06 | 6,191.87 | 3,876.57 | 2,738.44 |
Revenue | 1,124.90 | 4,118.63 | 2,859.24 | 1,884.54 |
Profit After Tax | -18.82 | 81.85 | 12.54 | -196.53 |
Net Worth | 2,031.77 | 2,049.59 | 831.12 | 507.65 |
Reserves and Surplus | 1,282.44 | 1,282.02 | 334.26 | 125.40 |
Total Borrowing | 250.00 | 250.00 | 250.00 | 250.00 |
Niva Bupa Health Insurance IPO Key Performance Indicator
The market capitalization of Niva Bupa Health Insurance IPO is Rs 13380.91 Cr.
KPI as of June 30, 2024.
KPI | Values |
---|---|
Debt/Equity | 0.12 |
RoNW | -0.92 |
P/BV | 6.14 |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 0.48 | -0.42 |
P/E (x) | 153.7 | -177.74 |
Niva Bupa Health Insurance IPO Objectives
- Augmentation of its capital base to strengthen solvency levels and
- General corporate purposes
Niva Bupa Health Insurance IPO Lot Size
Investors can bid for a minimum of 200 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 200 | ₹14,800 |
Retail (Max) | 13 | 2600 | ₹192,400 |
S-HNI (Min) | 14 | 2,800 | ₹207,200 |
S-HNI (Max) | 67 | 13,400 | ₹991,600 |
B-HNI (Min) | 68 | 13,600 | ₹1,006,400 |
Niva Bupa Health Insurance IPO Details
IPO Date | November 7, 2024 to November 11, 2024 |
Listing Date | [.] |
Face Value | ₹10 per share |
Price Band | ₹70 to ₹74 per share |
Lot Size | 200 Shares |
Total Issue Size | 297,297,297 shares (aggregating up to ₹2,200.00 Cr) |
Fresh Issue | 108,108,108 shares (aggregating up to ₹800.00 Cr) |
Offer for Sale | 189,189,189 shares of ₹10 (aggregating up to ₹1,400.00 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Share holding pre issue | 1,700,122,985 |
Share holding post issue | 1,808,231,093 |
Niva Bupa Health Insurance IPO Company Overview and Services
Established in 2008, Niva Bupa Health Insurance Company Limited is a prominent player in India’s health insurance sector. Formed as a joint venture between the Bupa Group and Fettle Tone LLP, the company specializes in health insurance solutions.
Niva Bupa offers a comprehensive health ecosystem, accessible through its Niva Bupa Health mobile app and website, ensuring a seamless experience for customers. Their products are designed to meet a range of needs, with retail plans tailored for individuals and families, and group products for employer-employee coverage.
As of March 31, 2024, Niva Bupa insured 14.73 million active lives, demonstrating significant reach and trust. Operating across 22 states and four union territories, the company has built a strong presence throughout India.
Niva Bupa’s financial growth is impressive, with a CAGR of 41.27% in Gross Written Premiums (GWP) from FY 2022 to FY 2024, including a 33.41% CAGR from retail health products alone.
A dedicated telemarketing team of 410 employees leverages advanced technology, including machine learning for lead scoring, product recommendations, and real-time CRM dashboards, to optimize customer engagement and conversions.
Niva Bupa Health Insurance IPO SWOT Analysis
Strengths
- Strong Market Presence: Niva Bupa has established itself across 22 states and 4 union territories in India, covering 14.73 million active lives, indicating a solid market reach.
- Growth in Premiums: The company’s Gross Written Premium (GWP) growth has been robust, with a CAGR of 41.27% from FY 2022 to FY 2024, driven by strong demand in both retail and group segments.
- Advanced Digital Ecosystem: Niva Bupa’s mobile app and website provide an integrated health ecosystem, making it easy for customers to access services and manage policies digitally.
- Technology-Driven Sales: The telemarketing team uses machine learning for lead scoring, product recommendations, and a real-time CRM, boosting customer engagement and conversions.
Weaknesses
- Dependence on Telemarketing: A significant portion of sales relies on telemarketing, which may limit customer acquisition channels and impact scalability in certain demographics.
- High Competition: The health insurance sector in India is highly competitive, with several established players, which could pressure Niva Bupa to continually enhance services and innovate.
Opportunities
- Expanding Health Insurance Market: With growing health awareness and insurance adoption in India, there is strong potential for Niva Bupa to capture a larger market share.
- Rising Demand for Digital Health Solutions: As customers increasingly seek digital-first insurance solutions, Niva Bupa’s app and digital services position it well to leverage this trend.
- Corporate and SME Coverage Growth: Expanding its group products to cover more employers and SMEs could further boost GWP growth.
Threats
- Regulatory Risks: The insurance sector is heavily regulated, and changes in health insurance regulations could affect Niva Bupa’s operations and profitability.
- Economic Slowdown Impact: Economic downturns could impact discretionary spending, leading to reduced health insurance purchases or downgrades in policy coverage.
- Technological Disruptions: Rapid advancements in technology and evolving customer expectations require continuous investment in digital capabilities, posing a risk if the company cannot keep pace.
This SWOT analysis reflects Niva Bupa’s strengths in market reach and technology, potential growth areas in digital and corporate segments, and challenges due to high competition, regulatory requirements, and evolving market dynamics.
Niva Bupa Health Insurance IPO GMP Details
Niva Bupa Health Insurance IPO last GMP is ₹3, last updated Nov 11th 2024. With the price band of 74.00, Niva Bupa Health Insurance IPO’s estimated listing price is ₹77 (cap price + today’s GMP).The expected percentage gain/loss per share is 4.05%.
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Estimated Listing Price | Last Updated |
---|---|---|---|---|---|
11-11-2024 Close | 74.00 | ₹3 | 500/7000 | ₹77 (4.05%) | 11-Nov-2024 8:31 |
10-11-2024 | 74.00 | ₹3 | 500/7000 | ₹77 (4.05%) | 10-Nov-2024 22:23 |
09-11-2024 | 74.00 | ₹3 | 500/7000 | ₹77 (4.05%) | 9-Nov-2024 22:23 |
08-11-2024 | 74.00 | ₹0 | — | ₹74 (0%) | 8-Nov-2024 22:29 |
07-11-2024 Open | 74.00 | ₹0 | — | ₹74 (0%) | 7-Nov-2024 22:32 |
What is IPO GMP?
The grey market premium (GMP) reflects the unofficial trading price of an IPO before its listing, offering insights into its potential market performance. A positive GMP indicates that the IPO may yield profits, while a negative GMP suggests a possible discount upon listing. However, it’s essential to recognize that IPO GMP can be highly volatile. Therefore, investors should not make decisions solely based on the GMP but should thoroughly assess all relevant factors before investing.
Want to Raise money for your company through SME IPO? Read More
Niva Bupa Health Insurance IPO subscription status
Niva Bupa Health Insurance IPO Subscription Status
Niva Bupa Health Insurance IPO subscribed 1.39 times. The public issue subscribed 2.01 times in the retail category, 1.62 times in QIB, and 0.50 times in the NII category by November 11, 2024.
Investor Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Rs Cr.)* |
---|---|---|---|---|
Anchor Investors | 1 | 13,37,83,783 | 13,37,83,783 | 990.000 |
Qualified Institutions | 1.62 | 8,91,89,190 | 14,47,72,400 | 1,071.316 |
Non-Institutional Buyers | 0.50 | 4,45,94,595 | 2,21,23,400 | 163.713 |
bNII (bids above ₹10L) | 0.55 | 2,97,29,730 | 1,63,84,600 | 121.246 |
sNII (bids below ₹10L) | 0.39 | 1,48,64,865 | 57,38,800 | 42.467 |
Retail Investors | 2.01 | 2,97,29,730 | 5,96,34,000 | 441.292 |
Total ** | 1.39 | 16,35,13,515 | 22,65,29,800 | 1,676.321 |
Total Application : 2,43,645
Note:
-
*: “Shares Offered” and “Total Amount” are calculated based on the upper price of the issue price range.
-
**: The portion of anchor investors (or market makers) is not included in the total number of shares offered.
Niva Bupa Health Insurance IPO Subscription Details (times)
Date | QIB | NII | Retail | Total |
---|---|---|---|---|
Day 1 Nov 7, 2024 |
0.83 | 0.35 | 0.76 | 0.69 |
Day 2 Nov 8, 2024 |
1.59 | 0.42 | 1.43 | 1.24 |
Day 3 Nov 11, 2024 |
1.62 | 0.50 | 2.01 | 1.39 |
Niva Bupa Health Insurance IPO Allotment status
The allotment status of Niva Bupa Health Insurance IPO is expected to be available on November 12, 2024.
Niva Bupa Health Insurance IPO allotment status is not available at this time. Niva Bupa Health Insurance IPO – The allotment status will be available once the basis of allotment is finalized. Please revisit us to check the latest updates for Niva Bupa Health Insurance Company Limited IPO allotment status.
To check Niva Bupa Health Insurance IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
On securing the allotment, you will receive the credit of equivalent shares in your Demat account.
If you have any concerns or queries about the allotment status, contact Kfin Technologies Limited either by phone or email. Investors can call on 04067162222, 04079611000 or send an email with all relevant details to nivabupa.ipo@kfintech.com.
Niva Bupa Health Insurance IPO Contact Details
Niva Bupa Health Insurance Company Limited
C-98, 1st Floor
Lajpat Nagar, Part 1
South Delhi, New Delhi-110024
Phone: +91 1246354900
Email: investor@nivabupa.com
Website: https://www.nivabupa.com/
Niva Bupa Health Insurance IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: nivabupa.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Niva Bupa Health Insurance IPO Prospectus
Niva Bupa Health Insurance IPO Lead Managers
- ICICI Securities Limited
- Morgan Stanley India Company Pvt Ltd
- Kotak Mahindra Capital Company Limited
- Axis Capital Limited
- Hdfc Bank Limited
- Motilal Oswal Investment Advisors Limited
Disclaimer: Investing in Initial Public Offerings (IPOs) involves substantial risk, and financial returns are not guaranteed. The information provided should not be construed as financial or investment advice. Prospective investors are advised to consider their financial situation, investment objectives, and risk tolerance before participating in an IPO. It is recommended to consult with a qualified financial advisor or professional before making any investment decisions. Past performance is not indicative of future results. Investments in IPOs may be subject to market risk, including the potential loss of principal.